Suzuki, Kei

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell

Lung Cancer Treatments and MutationsLung Cancer Research Studies

Cited by 820

Vascular invasion identifies the most aggressive histologic subset of stage I lung adenocarcinoma: Implications for adjuvant therapy

Yambayev, I., Sullivan, T. B., Rieger-Christ, K. M., Servais, E. L., Stock, C. T., Quadri, S. M., Sands, J. M., Suzuki, K., & Burks, E. J. (2022) · Lung Cancer

Lung Cancer Diagnosis and TreatmentLung Cancer Research Studies

Cited by 13

Vascular Invasion Predicts Recurrence in Stage IA2-IB Lung Adenocarcinoma but not Squamous Cell Carcinoma

Suaiti, L., Sullivan, T. B., Rieger-Christ, K. M., Servais, E. L., Suzuki, K., & Burks, E. J. (2023) · Clinical Lung Cancer

Lung Cancer Diagnosis and TreatmentLung Cancer Research Studies

Cited by 11